This suggests that cf-mtDNA content and deletion ratios may help differentiate between iPD and LRRK2-PD and highlight differing mitochondrial pathophysiology in these diseases (Puigròs et al. 2022). The gene discussed is LRRK2; the disease is Parkinson disease.